Clinical trials
Completed Hematologic Neoplasms trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
27 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2009 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 3 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 6 |
| 2024 | 2 |
| 2025 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 27 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Chinese PLA General Hospital | 2 |
| He Huang | 2 |
| Institute of Hematology & Blood Diseases Hospital, China | 2 |
| Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 2 |
| Affiliated Hospital to Academy of Military Medical Sciences | 1 |
| AstraZeneca | 1 |
| Beckman Coulter, Inc. | 1 |
| Children's Hospital of Fudan University | 1 |
| First Affiliated Hospital of Zhejiang University | 1 |
| Henan Cancer Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hematologic Neoplasms | 27 |
| Hematologic Diseases | 6 |
| Neoplasms | 5 |
| Graft vs Host Disease | 2 |
| Lymphoma, Large B-Cell, Diffuse | 2 |
| Neoplasms by Site | 2 |
| Recurrence | 2 |
| Body Weight | 1 |
| COVID-19 | 1 |
| Heart Defects, Congenital | 1 |
Trials
Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.